Assessment of the use of transfusion therapy and complications in orthopedic surgery in patients with sickle-cell anemia: Retrospective study;Analyse des pratiques transfusionnelles et complications chez le patient drépanocytaire en situation de chirurgie orthopédique: Étude rétrospective

Transfusion Clinique et Biologique

Volumn 10, Issue 2, 2003, Pages 61-66

  Amar, A K Ould ^a   Delattre, O ^b   Godbille, C ^b   Bera O ^b   Halbout, P A ^a   Catonne Y ^b  

^a Hopital P Zobda Quitman   (Martinique)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

Hemoglobinopathy; Operative transfusion; Orthopedic surgery; Sickle cell anemia

Indexed keywords

ADULT; ANEMIA; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FEMUR HEAD NECROSIS; HEMOGLOBIN SC DISEASE; HEMOGLOBINOPATHY; HEMOLYSIS; HEMORRHAGIC SHOCK; HUMAN; LUNG DISEASE; MALE; MORBIDITY; MORTALITY; ORTHOPEDIC SURGERY; PREOPERATIVE CARE; PROPHYLAXIS; SICKLE CELL ANEMIA; TOTAL HIP PROSTHESIS;

EID: 0038782088     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(03)00021-1     Document Type: Article

References (26)

1. Homi J, Reynolds J, Skiner A, et al. General anesthesia in sickle-cell disease. Br Med J 1979;1:1599-601.
2. Ebong WW, Kolawole TM. Aseptic necrosis of the femoral head in sickle-cell disease. Br J Rheumatol 1986;25:34-9.
3. Vichinsky EP, Neumayr LD, Haberken C, et al. The perioperative complication rate of orthopedic surgery in sickle cell disease: Report of the National Sickle Cell Surgey Study Group. Am J Hematol 1999;62:129-38.
4. Milner PF, Kraus AP, Sebes JI, et al. Sickle-cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991;325:1476-81.
5. Acurio MT, Friedman RJ. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br 1992;74:367-71.
6. Mukisi-Mukasa M, Elabaz A, Samuel-Leborgne, et al. Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle-cell disease. Orthopedics 2000;23:357-63.
7. Carayon A. Hétérozygotisme AS et lésions osseuses. Bull Soc Med Afr Noire 1967;12:596-601.
8. Nachamie BA, Dorfman HD. Ischemic necrosis of bone in sickle-cell trait. Mt Sinai J Med 1974;41:527-36.
9. Taylor Philip W, Thore William P, et al. Osteonecrosis in sickle-cell trait. J Rheumatol 1986; 13:643-6.
10. cs journées d'orthopédie de Fort-de-France. 9-13 février 1998.
11. Garden MS, Grant RE, Jebraili S. Peri-operative complications in patients with sickle-cell disease. Am J Orthop 1996;25:353-6.
12. Moran MC. Osteonecrosis of the hip in sickle-cell hemoglobinopathy. Am J Orthop 1995;24:18-24.
13. Vichinsky Elliot P, Haberkern Charles M, Lynne Neumayr, Earles Ann Noonan, et al. Comparaison of conservative and aggressive transfusion regimens in the peri-operative management of sicklecell disease. N Engl J Med 1995;333:206-13.
14. Koshy M, Weiner SJ, Miller ST, Sleeper LA, et al. Surgery and anesthesia in sickle-cell disease. Cooperative Study of Sickle-Cell Disease. Blood 1995;86:3676-84.
15. Simon TL, Alverson DC, Aubuchon J, Cooper ES, et al. Practice parameter for the use of red blood cell transfusions: developed by the red blood cell administration practice guideline development task force of the college of american pathologists. Arch Pathol Lab Med 1998;122:130-8.
16. Janik JS, Seeler RA. Perioperative management of children with sickle hemoglobinopathy. J Pediatr Surg 1980;15:117-20.
17. Haberkern CM, Neumayr LD, Orringer EP, Earles AN, Black D, Abboud MR, et al. Cholecystectomy in sickle cell anemia patients: peri-operative outcome of 364 cases from the National preoperative Transfusion Study. Pre-operative Transfusion in Sickle-cell disease Study Group. Blood 1997;89:1533-42.
18. Bischoff Robert J, Williamson Adrian, Dalali Michael J, Rice Janet C, Kerstein Morris D. Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies. Ann Surg 1988;207:434-8.
19. Fullerton MW, Philipart AI, Samalk S, Lusher JM. Pre-operative exchange transfusion in sickle cell anemia. J Pediatr Surg 1981;16: 297-300.
20. Schmalzer E, Chien S, Brown AK. Transfusion therapy in sickle cell disease. Am J Pediatr Hematol/Oncol 1982;4:395-406.
21. Win Nay, Doughty Heidi, Tefer Paul, et al. Hyperhemolytic transfusion reaction in sickle-cell disease. Transfusion 2001;41:323-8.
22. Famodu AA. Plasma fibrinolytic activity in sickle-cell disease. Trop Geogr Med 1988;40:331-3.
23. Hagger D, Wolff S, Owen J, et al. Changes in coagulation and fibrinolysis in patients with sickle-cell disease compared with healthy black controls. Blood Coagul Fibrinolysis 1995;6:93-9.
24. Bayazit AK, Kilinc Y. Natural inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state. Pediatr Int 2001;43:592-6.
25. De Montalembert M, Beauvais P, Bachir D, et al. Cerebrovasular accidents in sickle-cell disease. Risk factors and blood transfusion influence. French Study Group on sickle-cell disease. Eur J Pediatr 1993;152:201-4.
26. Warth JA. Hypertension and seizure following transfusion in an adult with sickle-cell anemia. Arch Intern Med 1984;144:607-8.